Skip to content

Can ketamine and other glutamate receptor modulators be considered entactogens?

Hiroe Hu, Alaina N Tillman, Miyu Fujita, Mayu Yoshikawa, Elizabeth D. Ballard, Yoojin Lee, Carlos A. Zarate

Psychiatry Research July 1, 2025 DOI: 10.1016/j.psychres.2025.116513 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review Peer reviewed
Sample size 30
Population Studies including human participants with self-reported ratings, neuroimaging, and/or behavioral task outcomes
Interventions Ketamine d-cycloserine
Topics Ketamine Esketamine
Keywords Entactogen Glutamate receptor modulators Prosocial behavior D-cycloserine Psychopharmacology psychotropic drugs Psychiatric medication Social cognition Therapeutic compounds pharmaceuticals Empathy emotional intelligence Social awareness
Citations 2
Key findings Ketamine and d-cycloserine may modulate self- and other-perception through changes in brain activity related to empathy and mentalizing.

Abstract

Subanesthetic-dose ketamine has recently been reported to improve hedonic pleasures associated with social interactions and altruism in individuals with treatment-resistant depression. However, whether ketamine-among other glutamate receptor modulators-also improves empathy and/or prosocial behavior in humans remains unknown. Under a framework grounded in neurobiology that proposes that prosocial behavior is preceded by empathy, this systematic review sought to: (1) explore the entactogenic effects of glutamate receptor modulators observed in clinical trials (as either primary or secondary outcomes), and (2) synthesize the findings regarding which glutamate receptor modulators produce entactogenic effects. Thirty studies that included self-reported ratings, neuroimaging, and/or behavioral task outcomes met inclusion criteria suggesting potential entactogenic effects associated with ketamine and, to less convincing extent, d-cycloserine (DCS). The findings suggest that ketamine and DCS may modulate self- and other-perception, involving changes in activity in brain regions involved in empathetic concerns and mentalizing, the ability to understand one's own and others' thoughts and feelings. These findings may guide potential therapeutic interventions for neuropsychiatric conditions associated with impaired empathy and prosocial behavior, including mood disorders, neurodevelopmental disorders, psychotic disorders, and personality disorders.

Comparable studies

Other systematic reviews and meta-analyses on ketamine, most cited first.

Study Year Design Participants
The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis Depressed patients with suicidal ideation at baseline 2017 Systematic review and individual participant data meta-analysis n = 167
Ketamine use: a review Ketamine users 2011 Systematic review
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression Participants with major depression in placebo-controlled, double-blind, randomized... 2015 Systematic review and meta-analysis
Ketamine and postoperative pain – a quantitative systematic review of randomised trials Surgical patients from 25 countries 2004 Systematic review n = 2,839
Side-effects associated with ketamine use in depression: a systematic review. Patients with depression 2018 Systematic review

Citations in the library

Explore topics